Scott Striplin, MD
Obstetrics & Gynecology · Covington, LANPI 1205830775
Payments from drug & device makers
Across 1,140 payments — averaging $5383.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Modernatx, Inc.$2.5M
- GSK$969K
- Pfizer$899K
- Sanofi Pasteur Inc.$508K
- Eli Lilly$462K
- Novavax Inc$354K
- plus $412K from 32 others
Across 12 payments — averaging $1278.14 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$14K
- Sanofi Pasteur Inc.$2K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Modernatx, Inc. | 460 | $2,532,510 |
| GSK | 258 | $969,097 |
| Pfizer | 88 | $899,417 |
| Sanofi Pasteur Inc. | 30 | $507,657 |
| Eli Lilly | 13 | $462,429 |
| Novavax Inc | 22 | $354,318 |
| Bavarian Nordic A/s | 37 | $125,020 |
| Sanofi US Services Inc. | 60 | $92,954 |
| AstraZeneca | 2 | $72,559 |
| Currax Pharmaceuticals LLC | 12 | $71,436 |
| Chugai Pharmaceutical Co., Ltd. | 6 | $25,653 |
| Abbott | 1 | $8,000 |
| Vertex | 1 | $7,583 |
| CSL Behring | 9 | $4,027 |
| Mylan Inc. | 1 | $2,404 |
| AbbVie | 57 | $871 |
| Astellas Pharma US Inc | 10 | $218 |
| Avion Pharmaceuticals | 15 | $205 |
| Mayne Pharma Commercial LLC | 16 | $183 |
| Therapeuticsmd, Inc. | 7 | $111 |
| Organon | 6 | $102 |
| Aspira Women's Health Inc | 1 | $85 |
| Scynexis, Inc. | 4 | $79 |
| Millicent US Inc | 4 | $64 |
| Merck | 3 | $47 |
| Novo Nordisk | 3 | $45 |
| Ascend Therapeutics US, LLC | 1 | $39 |
| Evofem Biosciences, Inc. | 2 | $29 |
| Mylan Pharmaceuticals Inc. | 2 | $28 |
| Duchesnay USA Incorporated | 1 | $24 |
| Bayer | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Mission Pharmacal Company | 1 | $18 |
| Agile Therapeutics, Inc. | 1 | $15 |
| Vertical Pharmaceuticals, LLC | 1 | $14 |
| Lupin Inc. | 1 | $14 |
| Myovant Sciences Inc. | 1 | $13 |
How this compares
$6,137,324 in reported general payments places this provider in the 95th percentile of 608 obstetrics & gynecology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other obstetrics & gynecology in Covington
- Katherine WilliamsCovington$15K
- Julie LandryCovington$9K
- Jamie HymelCovington$7K
- Kelly BrewsterCovington$7K
- Alison RodriguezNew Orleans$10.5M
- Samuel AlexanderMetairie$2.6M
- Blake LandrySlidell$2M
- Clifton Nicholson-UhlMarrero$1.7M
- Brandon PerezMarrero$888K
- Earl PeeperNew Orleans$374K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.